Study casts doubt on value of thalidomide against bone-marrow cancer

(AP) - Thalidomide, a drug that caused ghastly birth defects a generation ago but has been resurrected in recent years as a promising cancer treatment, failed in a study to prolong the lives of patients with multiple myeloma....More